The Clorox Company (CLX)
NEUTRALFundamental
47
Precio
$104.43
Capitalización Bursátil
$12.98B
Parte 1 · Cuánto vale la empresa
Resumen
Clorox makes household staples sold under well-known names: bleach and cleaning sprays under its own Clorox brand, trash bags under Glad, charcoal under Kingsford, and personal-care and health products including Burt's Bees. It manufactures most of what it sells, ships it to large retailers, and relies on repeat, habitual purchases rather than one-off sales — a household restocks bleach or trash bags on a predictable cycle regardless of the wider economy.
Cómo genera ingresos
Revenue comes from selling packaged goods to a concentrated set of large retailers, who then resell to shoppers. Margins depend on the cost of raw materials such as resin and chemicals, on manufacturing efficiency, and on holding shelf space and brand loyalty against cheaper private-label alternatives that retailers sell alongside Clorox's own products. The company reports results across four segments split by product category and by U.S. versus international markets.
Ingresos por segmento
Cleaning and disinfecting products under Clorox, plus water filtration under Brita and vitamins under Natural Vitality.
Trash bags under Glad, cat litter under Fresh Step and Scoop Away, and charcoal under Kingsford.
Food products including Hidden Valley dressings, and personal care through Burt's Bees.
The same core product categories sold outside the United States, mainly in Latin America and Canada.
Ventaja competitiva
Marca · EstrechaNames like Clorox, Glad and Kingsford have been the default choice on U.S. shelves for generations, which lets the company hold shelf space and charge more than an unbranded equivalent. The advantage is narrow: retailer store brands compete directly in nearly every category, and a large retailer with real pricing leverage can push back hard on Clorox's terms.
Qué impulsa la demanda
DefensivoCleaning products, trash bags and personal care items are routine, non-discretionary household purchases that people keep buying in a downturn, which makes volume relatively stable across the economic cycle. The bigger swings in results tend to come from input-cost inflation and from consumers trading down to private label when money is tight, not from skipping the purchase altogether.
Riesgos clave
- Retailer concentration — With Walmart alone worth nearly 27% of net sales, large retailers have the leverage to demand better pricing terms or to favour their own private-label products over Clorox's brands.
- Input cost and supply chain disruption — Volatile commodity, packaging, labour, energy and logistics costs, along with the risk of supply disruption from conflicts such as those in Ukraine, the Middle East, or tensions between China and Taiwan, can raise costs faster than prices can be adjusted.
- Cybersecurity — The company depends heavily on information technology systems and has already suffered a major cyberattack, in August 2023, that disrupted operations; a repeat incident could again halt production and shipments.
- Private-label competition — Store-brand alternatives, often priced well below Clorox's products, compete in nearly every category the company sells in, forcing continued spending on marketing and innovation to defend market share.
Concentración de clientes
Los principales clientes representan el 27% de los ingresos
Walmart and its affiliates accounted for nearly 27% of net sales in fiscal 2025, giving a single retailer significant leverage over shelf placement, promotional terms and pricing.
Los argumentos a favor
Buyers argue that Clorox's brands are habit-forming staples that hold shelf space no private label can fully dislodge, and that the company's cost-savings programme and full recovery from the 2023 cyberattack position it to grow margins even on roughly flat sales.
Los argumentos en contra
Sellers worry that with Walmart alone worth over a quarter of sales, Clorox has limited room to push back on retailer demands, and that persistent private-label competition plus input-cost inflation could keep squeezing volumes and margins at the same time.
Written by the editors, published on 18 de agosto de 2026
Direct competitors
Who this company fights with for the same customers
No editorial profile for this company yet
No competitor list for this company yet.
Balance y Liquidez
Ingresos
$6.76B
Últimos 12 meses (hasta 31/3/2026)
Beneficio Neto
$756M
Últimos 12 meses (hasta 31/3/2026)
Flujo de Caja Libre
$761M
Patrimonio Neto Total
$321M
Pasivo Total
$5.08B
Ratio de Liquidez
0.84
Cobertura de Intereses
-
Deuda/EBITDA
3.94
Beneficio Por Acción
Ingresos y Beneficio Neto
Flujo de Caja Libre
Desglose de Ingresos
Estado histórico
Márgenes en el tiempo
La deuda en el tiempo
Cuánto pesa la deuda
Cuadro de crecimiento
Crecimiento — Ingresos
Estimación de Valor Justo
Valor Justo
$110.05
Precio Actual
$104.43
Margen de Seguridad
+5.1%
Rango de Valor Justo
$71.53 - $148.56
Métodos de Estimación
Métricas de Valoración
Ratio P/E
17.40
ROE
252.3%
Ratio P/B
40.43
P/FCF
34.10
Margen Bruto
43.8%
ROIC
-
Radar de Rentabilidad
Value Creation (Economic Moat)
ROIC
-
WACC
6.3%
ROIC − WACC
-
Criterios de Análisis Fundamental
Superado (11)
- EPS shows upward trend
- Gross Margin 43.8%
- Positive Free Cash Flow
- Current Ratio
- Debt/EBITDA
- Return on Tangible Assets
- ROE 181.1%
- Earnings Quality (OCF/NI) 0.76
- Share Dilution -0.2%
- Net Margin Trend 11.2% vs 9.9%
- Piotroski F-Score 8/9
Fallido (12)
- EPS CAGR 4.22%
- Price CAGR -1.17%
- P/FCF 34.10
- P/B Ratio 40.43
- Debt/Equity ratio
- CapEx intensity
- Low reliance on intangibles
- Price below Graham Number
- DCF valuation (Fairly valued)
- Revenue Growth 5Y -1.8%
- Analyst Consensus 4% Buy
- Earnings Surprise avg 1.8%
No disponible (5)
- ROIC NaN%
- Dividend Payout NaN%
- Operating Margin NaN%
- Interest Coverage
- PEG Ratio (need PE > 0 and growth > 0)
Piotroski F-Score
Solidez financiera fuerte
Calidad de los Beneficios
Moderada: cierta brecha entre beneficios y efectivo
Dilución de Acciones
Recomprando acciones. Favorable para el accionista
Gobernanza
Equipo Directivo
| Nombre | Cargo | Edad |
|---|---|---|
| Ms. Linda J. Rendle | CEO & Chairman | 47 |
| Mr. Luc Bellet | Executive VP & CFO | 46 |
| Ms. Nina Barton | Executive VP and Chief Growth & Strategy Officer | 51 |
| Ms. Laura E. Peck | VP, Chief Accounting Officer & Corporate Controller | 48 |
| Ms. Kirsten M. Marriner | Executive VP & Chief Administrative Officer | 52 |
| Ms. Lisah Burhan | Vice President of Investor Relations | - |
Riesgo de Auditoría
7
Riesgo del Consejo
3
Riesgo de Compensación
6
Riesgo de Derechos del Accionista
8
Parte 2 · El precio y el momento de entrar
Esta parte no sirve para saber si la empresa vale: sirve para elegir cuándo comprarla, una vez que los fundamentales te han convencido. Dentro: análisis técnico, potencial, caídas históricas, exposición gamma.
Latest News
Recent headlines for CLX, sourced from Markets Gazette.
- 22d agoPOSITIVEClorox Expects Full-Year Sales Boost From Purell Deal
The Clorox Company announced fiscal fourth-quarter earnings that surpassed analyst forecasts, signaling resilience despite challenges. While sales volumes were down and the recent acquisition of GOJO Industries, the maker of Purell, incurred additional logistics costs, the overall financial performance indicates effective management. The company anticipates a full-year sales boost stemming from the Purell integration, suggesting a positive outlook for future revenue streams. Investors will be watching the successful integration of GOJO and its impact on Clorox's market position and profitability in the coming quarters.
via Markets Gazette